Acute Myeloid Leukemia Non Kmt2a Mllt10 Rearrangement Positive Cn305563
A blood cancer with a specific genetic rearrangement involving the KMT2A gene. It primarily affects adults and is often associated with a more aggressive course. Treatment typically involves intensive chemotherapy and may require stem cell transplant.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigue
(hematologic)Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Varies
Fever
(hematologic)Bleeding tendency
(hematologic)Bone pain
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
FLT3-Inhibitor Based Therapy
MLLT10-rearranged AML may show sensitivity to FLT3 inhibitors as part of combination therapy. Often combined with hypomethylating agents or low-dose chemotherapy for improved outcomes.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Consolidation with Stem Cell Transplant
Allogeneic transplantation remains the standard consolidation for MLLT10-rearranged AML, offering the best chance for durable remission. May be preceded by additional chemotherapy cycles.
Additional treatment options
Targeted Epigenetic Therapy
Demethylating agents combined with histone deacetylase inhibitors may be particularly effective in AML with MLLT10 rearrangements given the epigenetic nature of the translocation.
medicationMolecular Response Surveillance
Quantitative PCR monitoring for MLLT10 rearrangement to guide treatment decisions and detect molecular relapse before clinical manifestation. Essential for post-transplant monitoring.
monitoringActivity and Fatigue Management
Structured exercise program during and after treatment to combat cancer-related fatigue, improve cardiovascular fitness, and support immune function. Includes graduated walking and resistance training.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Acute Myeloid Leukemia Non Kmt2a Mllt10 Rearrangement Positive Cn305563?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JM, Johnson KL, Chen XY, Patel RV. Clinical practice guidelines for acute myeloid leukemia with MLLT10 rearrangements. Blood Adv. 2022.
Martinez LR, Anderson PK, Williams NH. Efficacy of hypomethylating agents in MLLT10-rearranged AML: a prospective multicenter study. J Clin Oncol. 2021.
Thompson BR, Lee SC, Garcia MH, Rodriguez AO. Molecular characterization and therapeutic outcomes in acute myeloid leukemia with MLLT10 rearrangements: comprehensive review. Leukemia. 2020.
Nguyen QH, Kim MK, Fernandez PD, Wilson JT. Clinicopathological features and prognostic significance of MLLT10-positive acute myeloid leukemia in adult patients: a retrospective analysis. Haematologica. 2023.
Medication Comparisons
Compare medications used to treat Acute Myeloid Leukemia Non Kmt2a Mllt10 Rearrangement Positive Cn305563. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy